Pericholangitis Clinical Presentation
- Author: Robert P Myers, MD, FRCPC; Chief Editor: BS Anand, MD more...
Symptoms of patients with pericholangitis vary considerably, depending on the reported series. Frequently, the diagnosis is made in asymptomatic patients with inflammatory bowel disease (IBD) when routine liver biochemistry studies reveal a cholestatic liver profile.
Other patients present with cholestatic features, including jaundice and pruritus. Jaundice may develop insidiously or occur as abrupt intermittent episodes of icterus. Finally, some patients may present with typical features of acute cholangitis—namely, fever, jaundice, and abdominal pain.
In a minority of patients, pericholangitis progresses to severe fibrosis and cirrhosis. In these patients, features of hepatic decompensation (eg, the development of ascites, edema, bleeding related to portal hypertension, or hepatic encephalopathy) may predominate.
The physical examination findings in patients with pericholangitis are usually unremarkable. Abnormal physical findings include the following:
Ascites and edema
Stigmata of chronic liver disease (spider angiomata), leukonychia, muscle wasting, gynecomastia and testicular atrophy (in men), and palmar erythema
Skin excoriations due to pruritus
Bambha K, Kim WR, Talwalkar J. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology. 2003 Nov. 125(5):1364-9. [Medline].
Mistilis SP. Pericholangitis and ulcerative colitis I. Pathology, etiology, and pathogenesis. Ann Intern Med. 1965. 63:1-16.
Wee A, Ludwig J, Coffey RJ. Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hum Pathol. 1985 Jul. 16(7):719-26. [Medline].
Nikolaidis NL, Giouleme OI, Tziomalos KA. Small-duct primary sclerosing cholangitis. A single-center seven-year experience. Dig Dis Sci. 2005 Feb. 50(2):324-6. [Medline].
Heikius B, Niemela S, Lehtola J. Hepatobiliary and coexisting pancreatic duct abnormalities in patients with inflammatory bowel disease. Scand J Gastroenterol. 1997 Feb. 32(2):153-61. [Medline].
Bayraktar Y, Arslan S, Saglam F. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?. Hepatogastroenterology. 1998 Nov-Dec. 45(24):2064-72. [Medline].
Kaplan G, Laupland K, Butzner D. Population-based study of the incidence of and the risk factors for developing primary sclerosing cholangitis. Gastroenterology. 2005. 128 (4 Suppl 2):A773.
Portela F, Magro F, Lago P, et al. Ulcerative colitis in a Southern European country: A national perspective. Inflamm Bowel Dis. 2009 Oct 12. epub ahead of print. [Medline].
Bjornsson E, Boberg KM, Cullen S. Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut. 2002 Nov. 51(5):731-5. [Medline].
Angulo P, Lindor KD. Primary sclerosing cholangitis. Hepatology. 1999 Jul. 30(1):325-32. [Medline].
Ardesjo B, Portela-Gomes GM, Rorsman F, Grimelius L, Ekwall O. Identification of a novel staining pattern of bile duct epithelial cells in primary sclerosing cholangitis. Inflamm Bowel Dis. 2010 Feb. 16(2):305-11. [Medline].
Baraniskin A, Nöpel-Dünnebacke S, Schumacher B, Gerges C, Bracht T, Sitek B, et al. Analysis of U2 small nuclear RNA fragments in the bile differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders. Dig Dis Sci. 2014 Jul. 59(7):1436-41. [Medline].
Cannom RR, Kaiser AM, Ault GT, Beart RW Jr, Etzioni DA. Inflammatory bowel disease in the United States from 1998 to 2005: has infliximab affected surgical rates?. Am Surg. 2009 Oct. 75(10):976-80. [Medline].
Gisbert JP. Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding. Inflamm Bowel Dis. 2009 Nov 2. epub ahead of print. [Medline].
Larsen S, Bendtzen K, Nielsen OH. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Ann Med. 2010 Mar. 42(2):97-114. [Medline].
Giljaca V, Poropat G, Stimac D, Gluud C. Glucocorticosteroids for primary sclerosing cholangitis. Cochrane Database Syst Rev. 2010 Jan 20. CD004036. [Medline].
Karlsen TH, Schrumpf E, Boberg KM. Update on primary sclerosing cholangitis. Dig Liver Dis. 2010 Feb 19. epub ahead of print. [Medline].
Mizuno S, Hirano K, Tada M, et al. Bezafibrate for the treatment of primary sclerosing cholangitis. J Gastroenterol. 2010 Feb 3. epub ahead of print. [Medline].
Azeem N, Gostout CJ, Knipschield M, Baron TH. Cholangioscopy with narrow-band imaging in patients with primary sclerosing cholangitis undergoing ERCP. Gastrointest Endosc. 2014 May. 79(5):773-779.e2. [Medline].